Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-11-03

Clinical Trial Update: Tolerability of Using a Post-Treatment Topical Adjuvant Combination Following Fractional Radiofrequency Ablation [NA]

View source ↗

Summary

A completed clinical trial evaluating tolerability of a post-treatment topical adjuvant after fractional radiofrequency ablation for skin disorders.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Venus Concept | Conditions: Skin Disorders | NA | Status: COMPLETED | Results posted: 2020-11-03